Gianluca Pirozzi
SVP, Head of Development, Regulatory and Safety
Jenny Shum
VP for Global Rare Disease Corporate Affairs
About Jenny
Jenny Shum was appointed to lead Alexion global corporate affairs in April 2025 and is responsible for communications, policy and government affairs activities. Previously, Jenny was responsible for corporate affairs across AstraZeneca’s Europe & Canada Region and Alexion’s International Region.
Prior to joining AstraZeneca in 2017, Jenny held several roles of increasing responsibility in government affairs at AbbVie and previously at Weber Shandwick. Jenny holds a BSc from the University of Warwick – Warwick Business School, UK.
